Advances in stroke medicine
Author: Bruce CV Campbell
Published online: 13 January 2020
In reply: I thank Cheng and Richards for highlighting the important role of carotid endarterectomy for high grade symptomatic stenosis in stroke prevention. As this therapy was established in the 1990s,1,2 it was not a focus of the review published in the MJA.3 Nonetheless, carotid endarterectomy is still a central part of the therapeutic armamentarium to reduce the risk of recurrent stroke. The absolute risk reduction in recurrent stroke of about 14% for patients with 70–99% symptomatic stenosis (but not near‐occlusion) observed in the pivotal trials4 may not be as great in contemporary practice with the use of high potency statins and an early combined antiplatelet strategy with aspirin and clopidogrel. This intensive medical therapy is essential in patients with atherosclerotic stroke mechanisms, regardless of whether an endarterectomy is performed, given the risk of recurrent disease and plaque rupture in other regions of the vasculature.
Competing interests
References
- Barnett HJ, Taylor DW, Eliasziw M, et al. Benefit of carotid endarterectomy in patients with symptomatic moderate or severe stenosis. North American Symptomatic Carotid Endarterectomy Trial Collaborators. N Engl J Med 1998; 339: 1415–1425.
- Randomised trial of endarterectomy for recently symptomatic carotid stenosis: Final results of the MRC European Carotid Surgery Trial (ECST). Lancet 1998; 351: 1379–1387.
- Campbell BC. Advances in stroke medicine. Med J Aust 2019; 210: 367–374. https://www.mja.com.au/journal/2019/210/8/advances-stroke-medicine
- Orrapin S, Rerkasem K. Carotid endarterectomy for symptomatic carotid stenosis. Cochrane Database Syst Rev 2017; (6): CD001081.
Motor Neuron Disease Mortality Trends in Australia From 1986 to 2023: A Population-Based Study
Carol M. Y. Lee, Rupendra N. Shrestha, Julian Gold, Mark Stevenson, Kelly L. Williams, Lyndal Henden, Sandrine K. K. Chan Moi Fat, Zoe Zussa, Amanda Wright, Martin Jude, Mark A. S. Laidlaw, Willem J. R. Fokkink, Dominic B. Rowe
Mild traumatic brain injury and concussion and persisting post‐concussion symptoms: new guidelines to support evidence‐based assessment and management in Australia and Aotearoa New Zealand
Karen M Barlow, Jennie L Ponsford, Alice Theodom, Gill Cowen, Gavin A Davis, Vicki Anderson, Franz E Babl, David Cole, Jennifer Cullen, Stuart R Dalziel, Melinda Fitzgerald, Howard Flavell, Caroline Yates, Rebecca Kimble, John H Olver, Rhonda Orr, Mark Ralfe, Michael Rose, Nick Rushworth, Julia Treleaven, Gary Browne, Nathan Delang, Sarah Harris, Gary Mitchell, Sean Tweedy
The prevalence of and variation in indicators of the quality and safety of long term aged care in Australia, 2019: a cross‐sectional population‐based study
Tesfahun C Eshetie, Gillian E Caughey, Catherine Lang, Olivia Ryan, Renuka Visvanathan, Craig Whitehead, Keith Evans, Janet K Sluggett, Jyoti Khadka, Carolyn Dawkins, Helena Williams, Miranda Starke, Sara Blunt, Anne Liddell, Megan Corlis, Anna Sheppeard, Penelope Lello, Marilyn Thien, Steven L Wesselingh, Maria C Inacio
Health and economic benefits of improving pre‐hospital identification of stroke in Australian women: a modelling study
Thomas Gadsden, Lei Si, Emily R Atkins, Cheryl Carcel, Xia Wang, Stephen Jan, Mark Woodward, Laura E Downey
Symptom burden, quality of life, and diagnostic journey of people with postural orthostatic tachycardia syndrome, Australia, 2021–24: a descriptive patient registry data study
Marie‐Claire Seeley, Gemma Wilson, Eric Ong, Amy Langdon, Jonathan Chieng, Danielle Bailey, Kristina Comacchio, Amanda Page, Dennis H Lau, Celine Gallagher
The intersection of rurality and dementia prevalence in Australia for Aboriginal and Torres Strait Islander and non‐Indigenous peoples
Antonia J Clarke, Marwan Ahmed, Judith M Katzenellenbogen, John Towney (Wiradjuri), Anna H Balabanski, Adrienne Withall (Dharawal Yuin), Kylie Radford, Amy Brodtmann